Literature DB >> 17506237

Parkinson disease: managing a complex, progressive disease at all stages.

Monique L Giroux1.   

Abstract

Parkinson disease is a complex neurodegenerative disease with both motor and nonmotor symptoms. Levodopa remains the mainstay of therapy but is associated with motor complications as the disease progresses. A levodopa-sparing strategy may reduce or delay the onset of motor complications. New medical and surgical therapies offer improved control of motor complications in advancing disease. Recognition and treatment of nonmotor symptoms can improve quality of life throughout the course of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506237     DOI: 10.3949/ccjm.74.5.313

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  6 in total

1.  Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model.

Authors:  Gabriela Pérez-Barrón; José Guillermo Avila-Acevedo; Ana María García-Bores; Sergio Montes; Sara García-Jiménez; Ismael León-Rivera; Moisés Rubio-Osornio; Antonio Monroy-Noyola
Journal:  J Nat Med       Date:  2014-09-25       Impact factor: 2.343

2.  Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease.

Authors:  Frauke Adams; Michael Boschmann; Elmar Lobsien; Andreas Kupsch; Axel Lipp; Gabriele Franke; Marie Charlotte Leisse; Juergen Janke; Simone Gottschalk; Joachim Spranger; Jens Jordan
Journal:  Eur J Clin Pharmacol       Date:  2008-07-30       Impact factor: 2.953

3.  Palliative care in Parkinson's disease: role of cognitive behavior therapy.

Authors:  Samput Mallick
Journal:  Indian J Palliat Care       Date:  2009-01

4.  Part 2: Introduction to the Pharmacotherapy of Parkinson's Disease, With a Focus on the Use of Dopaminergic Agents.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-09

5.  Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial.

Authors:  Bahram Yousefi; Vahid Tadibi; Ali Fathollahzadeh Khoei; Ali Montazeri
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

6.  DOPA-sparing strategy in the treatment of young onset Parkinson's disease.

Authors:  Abdul Qayyum Rana; Mohamad Saleh; Muhammad Saad Yousuf; Wasim Mansoor; Syed Hussaini; Maniza Rahman; Zohair Iqbal
Journal:  J Neurosci Rural Pract       Date:  2016 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.